A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?

References

• Balashov KE, Rottman JB, Weiner HL, et al. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6873–6878. PubMed PMID: WOS:000080842200055; English. DOI:10.1073/pnas.96.12.6873
   PubMed Web of Science ®Google Scholar
• Traugott U, Reinherz EL, Raine CS. Multiple-sclerosis - distribution of T-cell subsets within active chronic lesions. Science. 1983;219(4582):308–310. PubMed PMID: WOS:A1983PX64500034; English. DOI:10.1126/science.6217550
   PubMed Web of Science ®Google Scholar
• Viglietta V, Baecher-Allan C, Weiner HL, et al. Loss of functional suppression by CD4(+)CD25(+) regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004 Apr 5;199(7):971–979. PubMed PMID: WOS:000220761000009; English. DOI:10.1084/jem.20031579
   PubMed Web of Science ®Google Scholar
• Esiri MM. Multiple-sclerosis - quantitative and qualitative study of immunoglobulin-containing cells in the central nervous-system. Neuropath Appl Neuro. 1980;61:9–21. PubMed PMID: ISI:A1980JJ25400002; English. DOI:10.1111/j.1365-2990.1980.tb00199.x
   PubMed Web of Science ®Google Scholar
• Cepok S, Jacobsen M, Schock S, et al. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain. 2001 Nov;124:2169–2176. PubMed PMID: ISI:000172295500005; English. DOI:10.1093/brain/124.11.2169
   PubMed Web of Science ®Google Scholar
• Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis [Research support, non-U.S. Gov’t]. Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11064–11069. PubMed PMID: 15263096; PubMed Central PMCID: PMC503741. eng. DOI:10.1073/pnas.0402455101
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Karnes WE, Bartleson JD, et al. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination [Case reports]. Neurology. 1993 Jun;43(6):1100–1104. PubMed PMID: 8170550; eng.
   PubMed Web of Science ®Google Scholar
• Steinman L, Rosenbaum JT, Sriram S, et al. In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7111–7114. PubMed PMID: 6947275; PubMed Central PMCID: PMCPMC349205.
   PubMed Web of Science ®Google Scholar
• Sriram S, Steinman L. Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J Exp Med. 1983 Oct 01;158(4):1362–1367. PubMed PMID: 6194246; PubMed Central PMCID: PMCPMC2187382.
   PubMed Web of Science ®Google Scholar
• Sriram S, Roberts CA. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. J Immunol. 1986 Jun 15;136(12):4464–4469. PubMed PMID: 3086430.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Lafuse WP, Leibowitz J, et al. Partial suppression of Theiler’s virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens) [Research support, non-U.S. Gov’t research support, U.S. Gov’t, P.H.S.]. Neurology. 1986 Jul;36(7):964–970. PubMed PMID: 3487048; eng.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Sriram S. Successful therapy of Theiler’s virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol. 1988 May 01;140(9):2950–2955. PubMed PMID: 2966203.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Kenny JJ, Thiemann RL, et al. Theiler’s virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene [Research support, non-U.S. Gov’t Research support, U.S. Gov’t, P.H.S.]. Microb Pathog. 1990 Jan;8(1):23–35. PubMed PMID: 2333032; eng.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system [Research support, non-U.S. Gov’t Research support, U.S. Gov’t, P.H.S.]. Ann Neurol. 1990 Jan;27(1):12–17. PubMed PMID: 2301922; eng. DOI:10.1002/ana.410270104.
   PubMed Web of Science ®Google Scholar
• Rodriguez M. Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells [Research support, non-U.S. Gov’t Research support, U.S. Gov’t, P.H.S.]. Lab Invest. 1991 Mar;64(3):358–370. PubMed PMID: 2002654; eng.
   PubMed Web of Science ®Google Scholar
• Miller DJ, Sanborn KS, Katzmann JA, et al. Monoclonal autoantibodies promote central-nervous-system repair in an animal-model of multiple-sclerosis. J Neurosci. 1994 Oct;14(10):6230–6238. PubMed PMID: ISI:A1994PL02800042; English.
   PubMed Web of Science ®Google Scholar
• Miller DJ, Njenga MK, Murray PD, et al. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler’s virus-induced demyelination. Int Immunol. 1996 Jan;8(1):131–141. PubMed PMID: ISI:A1996TT32900014; English. DOI:10.1093/intimm/8.1.131
   PubMed Web of Science ®Google Scholar
• van Oosten BW, Lai M, Hodgkinson S, et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology. 1997 Aug;49(2):351–357. PubMed PMID: 9270561.
   PubMed Web of Science ®Google Scholar
• Pavelko KD, Van Engelen BGM, Rodriguez M. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci. 1998 Apr 1;18(7):2498–2505. PubMed PMID: ISI:000072778700020; English.
   PubMed Web of Science ®Google Scholar
• Warrington AE, Asakura K, Bieber AJ, et al. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis [Research support, non-U.S. Gov’t Research support, U.S. Gov’t, P.H.S.]. Proc Natl Acad Sci U S A. 2000 Jun 06;97(12):6820–6825. PubMed PMID: 10841576; PubMed Central PMCID: PMC18751. eng.
   PubMed Web of Science ®Google Scholar
• Ure DR, Rodriguez M. Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. Faseb J. 2002 Jun;16(8):1260-+. PubMed PMID: ISI:000176683900032; English. DOI:10.1096/fj.01-1023fje.
   PubMed Web of Science ®Google Scholar
• Traugott U, Stone SH, Raine CS. Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery. J Neurol Sci. 1982 Oct;56(1):65–73. PubMed PMID: 6183403.
   PubMed Web of Science ®Google Scholar
• Raine CS, Traugott U. Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components. Lab Invest. 1983 Mar;48(3):275–284. PubMed PMID: 6186840.
   PubMed Web of Science ®Google Scholar
• Raine CS, Moore GR, Hintzen R, et al. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis. Lab Invest. 1988 Oct;59(4):467–476. PubMed PMID: 2459499.
   PubMed Web of Science ®Google Scholar
• Lang W, Rodriguez M, Lennon VA, et al. Demyelination and remyelination in murine viral encephalomyelitis. Ann N Y Acad Sci. 1984;436:98–102, PubMed PMID: 6085230
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Lennon VA, Benveniste EN, et al. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol. 1987 Jan;46(1):84–95. PubMed PMID: 2432195.
   PubMed Web of Science ®Google Scholar
• Huang DW, McKerracher L, Braun PE, et al. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron. 1999 Nov;24(3):639–647. PubMed PMID: 10595515.
   PubMed Web of Science ®Google Scholar
• Miller DJ, Rodriguez M. A monoclonal autoantibody that promotes central-nervous-system remyelination in a model of multiple-sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol. 1995 Mar 1;154(5):2460–2469. PubMed PMID: ISI:A1995QH29100046; English.
   PubMed Web of Science ®Google Scholar
• Hunter SF, Miller DJ, Rodriguez M. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. J Neurol Sci. 1997 Sep 10;150(2):103–113. PubMed PMID: ISI:A1997XQ32500002; English. DOI:10.1016/S0022-510x(97)00080-4.
   PubMed Web of Science ®Google Scholar
• Asakura K, Pogulis RJ, Pease LR, et al. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J Neuroimmunol. 1996 Mar;65(1):11–19. PubMed PMID: ISI:A1996UL41800002; English. DOI:10.1016/0165-5728(95)00175-1
   PubMed Web of Science ®Google Scholar
• Asakura K, Miller DJ, Murray K, et al. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res. 1996 Feb 1;43(3):273–281. PubMed PMID: ISI:A1996TT53000002; English. DOI:10.1002/(Sici)1097-4547(19960201)43:3<273::Aid-Jnr2>3.0.Co;2-G
   PubMed Web of Science ®Google Scholar
• Asakura K, Miller DJ, Pease LR, et al. Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci. 1998 Oct 1;18(19):7700–7708. PubMed PMID: ISI:000076060100008; English.
   PubMed Web of Science ®Google Scholar
• Lucchinetti CF, Noseworthy JH, Rodriguez M. Promotion of endogeneous remyelination in multiple sclerosis. Mult Scler. 1997 Apr;3(2):71–75. PubMed PMID: ISI:A1997XQ58200002; English.
   PubMedGoogle Scholar
• Miller DJ, Bright JJ, Sriram S, et al. Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody. J Neuroimmunol. 1997 May;75(1–2):204–209. PubMed PMID: ISI:A1997WV72800026; English. DOI:10.1016/S0165-5728(97)00027-1
   PubMed Web of Science ®Google Scholar
• van Engelen BGM, Pavelko KD, Rodriguez M. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. Mult Scler. 1997 Apr;3(2):76–79. PubMed PMID: ISI:A1997XQ58200003; English.
   PubMedGoogle Scholar
• Burger D, Simon M, Perruisseau G, et al. The epitope(s) recognized by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein. J Neurochem. 1990 May;54(5):1569–1575. PubMed PMID: 1691277.
   PubMed Web of Science ®Google Scholar
• Paz Soldan MM, Warrington AE, Bieber AJ, et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003 Jan;22(1):14–24. PubMed PMID: 12595235.
   PubMed Web of Science ®Google Scholar
• Miller DJ, Njenga MK, Parisi JE, et al. Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis. J Histochem Cytochem. 1996 Sep;44(9):1005–1011. PubMed PMID: ISI:A1996VF42900008; English.
   PubMed Web of Science ®Google Scholar
• Bieber A, Asakura K, Warrington A, et al. Antibody-mediated remyelination: relevance to multiple sclerosis [Research support, U.S. Gov’t, P.H.S Review]. Mult Scler. 2000 Oct;6 Suppl 2:S1-5; discussion S33. PubMed PMID: 11188771; eng.
   PubMedGoogle Scholar
• Achiron A, Pras E, Gilad R, et al. Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol. 1992 Dec;49(12):1233–1236. PubMed PMID: 1449400.
   PubMedGoogle Scholar
• Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol. 1997 Aug;100(2):151–157. PubMed PMID: 9275133.
   PubMed Web of Science ®Google Scholar
• Stangel M, Hartung HP, Marx P, et al. Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci. 1998 Jan 08;153(2):203–214. PubMed PMID: 9511879.
   PubMed Web of Science ®Google Scholar
• Ure DR, Rodriguez M. Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. Faseb J. 2002 Aug;16(10):1260–1262. PubMed PMID: 12060672. DOI:10.1096/fj.01-1023fje.
   PubMedGoogle Scholar
• Warrington AE, Rodriguez M. Method of identifying natural antibodies for remyelination [Research support, N.I.H., Extramural Research support, non-U.S. Gov’t]. J Clin Immunol. 2010 May;30 Suppl 1:S50–5. PubMed PMID: 20387101; PubMed Central PMCID: PMC4108241. eng. DOI:10.1007/s10875-010-9406-5
   PubMed Web of Science ®Google Scholar
• Bieber AJ, Warrington A, Asakura K, et al. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice [Research support, non-U.S. Gov’t Research support, U.S. Gov’t, P.H.S.]. Glia. 2002 Mar 01;37(3):241–249. PubMed PMID: 11857682; eng.
   PubMed Web of Science ®Google Scholar
• Mitsunaga Y, Ciric B, van Keulen V, et al. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. Faseb J. 2002 Jun;16(8):1325-+. PubMed PMID: ISI:000176683900023; English. DOI:10.1096/fj.01-0994fje
   PubMed Web of Science ®Google Scholar
• Wootla B, Denic A, Watzlawik JO, et al. Antibody-mediated oligodendrocyte remyelination promotes axon health in progressive demyelinating disease. Mol Neurobiol. 2016 Oct;53(8):5217–5228. PubMed PMID: 26409478; PubMed Central PMCID: PMCPMC5012151. DOI:10.1007/s12035-015-9436-3
   PubMed Web of Science ®Google Scholar
• Ciric B, van Keulen V, Soldan MP, et al. Antibody-mediated remyelination operates through mechanism independent of immunomodulation. J Neuroimmunol. 2004 Jan;146(1–2):153–161. PubMed PMID: ISI:000188500600018; English. DOI:10.1016/j.jneuroim.2003.11.002
   PubMed Web of Science ®Google Scholar
• Pirko I, Ciric B, Gamez J, et al. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. Faseb J. 2004 Aug;18(11):1577-+. PubMed PMID: ISI:000223554900007; English. DOI:10.1096/fj.04-2026fje
   Web of Science ®Google Scholar
• Warrington AE, Bieber AJ, Ciric B, et al. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res. 2007 Apr;85(5):967–976. PubMed PMID: ISI:000245726700005; English.
   PubMed Web of Science ®Google Scholar
• Mullin AP, Cui C, Wang Y, et al. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination. Neurobiol Dis. 2017 Sep;105:142–155. PubMed PMID: 28576706. DOI:10.1016/j.nbd.2017.05.015
   PubMed Web of Science ®Google Scholar
• Watzlawik J, Holicky E, Edberg DD, et al. Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes [Research support, N.I.H., extramural Research support, U.S. Gov’t, P.H.S.]. Glia. 2010 Nov 15;58(15):1782–1793. PubMed PMID: 20645409; PubMed Central PMCID: PMC2967300. eng. DOI:10.1002/glia.21048
   PubMed Web of Science ®Google Scholar
• Watzlawik JO, Warrington AE, Rodriguez M. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS One. 2013 Feb 1;8(2): ARTN e55149. PubMed PMID: ISI:000314597900017; English. DOI:10.1371/journal.pone.0055149
   PubMed Web of Science ®Google Scholar
• Eisen A, Greenberg BM, Bowen JD, et al. A double blind, placebo controlled, single ascending dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis. Mult Scler J Exp Transl Clin. 2017 Nov 21;3(4):2055217317743097.PMID:29348926
   Google Scholar
• Greenberg BMRM, Kantarci OH, Arnold D, et al. Safety and tolerability of the remyelinating therapeutic antibody rHIgM22 in patients with stable multiple sclerosis. Poster No - P4339 | ACO P5130, 67th AAN Annual Meeting | American Academy of Neurology®. 2015 April 18–25; Washington, DC: USA.
   Google Scholar
• Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 03;249(4968):505–510. PubMed PMID: 2200121.
   PubMed Web of Science ®Google Scholar
• Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990 Aug 30;346(6287):818–822. PubMed PMID: 1697402. DOI:10.1038/346818a0.
   PubMed Web of Science ®Google Scholar
• Nastasijevic B, Wright BR, Smestad J, et al. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. PLoS One . 2012;7(6):e39595. PubMed PMID: 22761835; PubMed Central PMCID: PMC3384608. DOI:10.1371/journal.pone.0039595.
   PubMed Web of Science ®Google Scholar
• Smestad J, Maher LJ 3rd. Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis. Nucleic Acids Res. 2013 Jan;41(2):1329–1342. PubMed PMID: 23175609; PubMed Central PMCID: PMC3553947. DOI:10.1093/nar/gks1093.
   PubMed Web of Science ®Google Scholar
• Perschbacher K, Smestad JA, Peters JP, et al. Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. Nucleic Acid Ther. 2015 Feb;25(1):11–19. PubMed PMID: 25536292; PubMed Central PMCID: PMC4296750.
   PubMed Web of Science ®Google Scholar
• Lemus HN, Warrington AE, Denic A, et al. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis. Hum Antibodies. 2017;25(3–4):121–129. PubMed PMID: 28269761. DOI:10.3233/HAB-170313
   PubMedGoogle Scholar
• Wootla B, Denic A, Watzlawik JO, et al. A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis. J Neuroinflammation. 2015 Apr 29;12:83. PubMed PMID: 25924771; PubMed Central PMCID: PMCPMC4418041. DOI:10.1186/s12974-015-0303-y
   PubMed Web of Science ®Google Scholar
• Warrington AE, Bieber AJ, Ciric B, et al. Immunoglobulin-mediated CNS repair [Research support, non-U.S. Gov’t Research support, U.S. Gov’t, P.H.S. review]. J Allergy Clin Immunol. 2001 Oct;108(4 Suppl):S121–5. PubMed PMID: 11586279; eng.
   PubMed Web of Science ®Google Scholar
• Soldan MMP, Warrington AE, Bieber AJ, et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: redlationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003 Jan;22(1):14–24. PubMed PMID: ISI:000181353400002; English. DOI:10.1016/S1044-7431(02)00018-0
   PubMed Web of Science ®Google Scholar
• Ciric B, Howe CL, Soldan MP, et al. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol. 2003 Oct;13(4):608–616. PubMed PMID: ISI:000186614200016; English.
   PubMed Web of Science ®Google Scholar
• Howe CL, Bieber AJ, Warrington AE, et al. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis. 2004 Feb;15(1):120–131. PubMed PMID: ISI:000188755700013; English.
   PubMed Web of Science ®Google Scholar
• Warrington AE, Bieber AJ, Van Keulen V, et al. Neuron-binding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol. 2004 May;63(5):461–473. PubMed PMID: ISI:000221559400006; English.
   PubMed Web of Science ®Google Scholar
• Xu X, Wittenberg NJ, Jordan LR, et al. A patterned recombinant human IgM guides neurite outgrowth of CNS neurons. Sci Rep. 2013;3:2267. PubMed PMID: 23881231; PubMed Central PMCID: PMCPMC3721078. DOI:10.1038/srep02267
   PubMed Web of Science ®Google Scholar